taurocholic acid has been researched along with Diabetes Mellitus, Type 1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Salami, H; Golocorbin-Kon, S; Mathavan, S; Mikov, M | 1 |
| Bae, YH; Hwang, HS; Kim, KS; Kwag, DS; Lee, ES | 1 |
| Al-Salami, H; Arfuso, F; Chen-Tan, N; Mathavan, S | 1 |
3 other study(ies) available for taurocholic acid and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Diabetes development increased concentrations of the conjugated bile acid, taurocholic acid in serum, while treatment with microencapsulated-taurocholic acid exerted no hypoglycaemic effects.
Topics: Administration, Oral; Alginic Acid; Animals; Blood Glucose; Capsules; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 1; Drug Liberation; Drug Stability; Hypoglycemic Agents; Male; Rats; Rats, Wistar; Rheology; Tandem Mass Spectrometry; Taurocholic Acid | 2017 |
Immense Insulin Intestinal Uptake and Lymphatic Transport Using Bile Acid Conjugated Partially Uncapped Liposome.
Topics: Animals; Bile Acids and Salts; Blood Glucose; Caco-2 Cells; Diabetes Mellitus, Type 1; Humans; Hydrogen-Ion Concentration; Insulin; Intestine, Small; Liposomes; Male; Rats; Rats, Sprague-Dawley; Taurocholic Acid | 2018 |
A comprehensive study of novel microcapsules incorporating gliclazide and a permeation enhancing bile acid: hypoglycemic effect in an animal model of Type-1 diabetes.
Topics: Alginates; Animals; Bile Acids and Salts; Blood Glucose; Capsules; Cell Survival; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Drug Compounding; Excipients; Gliclazide; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Particle Size; Solubility; Taurocholic Acid | 2016 |